This episode examines retroviruses, enveloped positive-sense RNA viruses that replicate through reverse transcription and genomic integration. Drawing from Murray’s Chapter 54, it explores how this unique replication strategy reshapes host biology.
The defining feature is the enzyme reverse transcriptase, which converts viral RNA into complementary DNA. This DNA is transported into the nucleus and integrated into the host genome via integrase. Once integrated, the provirus becomes part of the host’s genetic architecture.
The central clinical focus is Human Immunodeficiency Virus (HIV). HIV targets CD4+ T lymphocytes, progressively impairing immune function and leading to acquired immunodeficiency syndrome (AIDS) if untreated.
Key concepts include:
Reverse transcription
Integration and latency
Immune depletion
Combination antiretroviral therapy (ART)
Viral load monitoring
Conceptually, retroviruses blur the boundary between viral and host genomes. Clinically, long-term management rather than eradication defines treatment.
Key Takeaways
Retroviruses replicate via reverse transcription
Viral DNA integrates into the host genome
HIV targets CD4+ T cells
Combination therapy reduces resistance
Viral load monitoring guides management
